Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,664,687
-
Share change
-
+3,068,246
-
Total reported value
-
$344,058,000
-
Price per share
-
$17.55
-
Number of holders
-
36
-
Value change
-
+$49,910,828
-
Number of buys
-
27
-
Number of sells
-
20
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q3 2021
As of 30 Sep 2021,
CYTEIR THERAPEUTICS INC - COM (CYTT) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,664,687 shares.
The largest 10 holders included
Novo Holdings A/S, FMR LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, BAKER BROS. ADVISORS LP, CAAS CAPITAL MANAGEMENT LP, ACUTA CAPITAL PARTNERS, LLC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.